ADIPOQ and Obesity: Consequently, observations in the present study may indicate that decreased production of adiponectin contributes to the systemic and vascular inflammation commonly found in obesity through its involvement within the regulatory pathway of several factors including TNF-α, IL-6, CRP, insulin resistance, body composition, and disease states.